Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma

Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or relapsed multiple myeloma, but explicit data for central nervous system lymphoma (CNSL) are lacking. Here, we treated 13 CNSL patients with ASCT sequenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiaying, Meng, Fankai, Cao, Yang, Zhang, Yicheng, Zhu, Xiaojian, Wang, Na, Wang, Jue, Huang, Lifang, Zhou, Jianfeng, Xiao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282870/
https://www.ncbi.nlm.nih.gov/pubmed/34267187
http://dx.doi.org/10.1038/s41408-021-00523-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282870/
https://www.ncbi.nlm.nih.gov/pubmed/34267187
http://dx.doi.org/10.1038/s41408-021-00523-2

Ejemplares similares